Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PTEN Phosphohydrolase | 14 | 2020 | 1117 | 0.810 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 1331 | 0.410 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2018 | 2948 | 0.350 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2016 | 2060 | 0.340 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3601 | 0.320 |
Why?
|
Prostatic Neoplasms | 11 | 2020 | 11094 | 0.310 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 249 | 0.300 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5329 | 0.300 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2801 | 0.290 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2456 | 0.290 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2024 | 3607 | 0.280 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18330 | 0.280 |
Why?
|
Mice | 41 | 2024 | 81889 | 0.260 |
Why?
|
Anilides | 2 | 2020 | 413 | 0.260 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13643 | 0.250 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 88 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5387 | 0.250 |
Why?
|
Cytochromes c | 1 | 2005 | 173 | 0.240 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2018 | 102 | 0.240 |
Why?
|
Cell Line, Tumor | 21 | 2024 | 17088 | 0.230 |
Why?
|
Pericytes | 2 | 2018 | 298 | 0.220 |
Why?
|
RNA, Ribosomal | 2 | 2019 | 227 | 0.220 |
Why?
|
Animals | 47 | 2024 | 168930 | 0.210 |
Why?
|
Indoles | 3 | 2019 | 1834 | 0.210 |
Why?
|
Pantothenic Acid | 1 | 2022 | 17 | 0.210 |
Why?
|
Nuclear Proteins | 6 | 2019 | 5795 | 0.200 |
Why?
|
Coenzyme A | 1 | 2022 | 39 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4891 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1405 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8621 | 0.190 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2022 | 125 | 0.190 |
Why?
|
Computational Biology | 1 | 2013 | 3564 | 0.190 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 8045 | 0.180 |
Why?
|
Caspases | 1 | 2004 | 881 | 0.180 |
Why?
|
Nipples | 1 | 2023 | 227 | 0.180 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1899 | 0.180 |
Why?
|
Androgen Receptor Antagonists | 1 | 2021 | 123 | 0.170 |
Why?
|
Sesquiterpenes | 1 | 2021 | 175 | 0.170 |
Why?
|
Lipogenesis | 2 | 2020 | 217 | 0.170 |
Why?
|
Glucose Transporter Type 3 | 1 | 2019 | 16 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2021 | 2881 | 0.160 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13485 | 0.160 |
Why?
|
Trans-Activators | 1 | 2009 | 2855 | 0.160 |
Why?
|
Dyskeratosis Congenita | 1 | 2019 | 70 | 0.160 |
Why?
|
Quinolines | 1 | 2024 | 769 | 0.160 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 496 | 0.160 |
Why?
|
Mutation | 10 | 2021 | 30213 | 0.160 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2355 | 0.150 |
Why?
|
Cytoplasm | 3 | 2013 | 1505 | 0.150 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2018 | 25 | 0.150 |
Why?
|
Databases, Factual | 1 | 2013 | 8066 | 0.150 |
Why?
|
Organoids | 2 | 2021 | 740 | 0.150 |
Why?
|
Caveolin 1 | 1 | 2019 | 255 | 0.150 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 135 | 0.140 |
Why?
|
Anticarcinogenic Agents | 1 | 2019 | 251 | 0.140 |
Why?
|
Lipoylation | 1 | 2018 | 87 | 0.140 |
Why?
|
Cell Proliferation | 10 | 2024 | 10445 | 0.140 |
Why?
|
Pyridines | 2 | 2020 | 2888 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 393 | 0.140 |
Why?
|
Growth and Development | 1 | 2016 | 46 | 0.140 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2823 | 0.140 |
Why?
|
Signal Transduction | 14 | 2022 | 23619 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3636 | 0.130 |
Why?
|
Apoptosis | 5 | 2021 | 9513 | 0.130 |
Why?
|
Cell Cycle Proteins | 2 | 2024 | 3439 | 0.130 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2056 | 0.130 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2016 | 42 | 0.130 |
Why?
|
DNA, Intergenic | 1 | 2016 | 108 | 0.130 |
Why?
|
Neoplasms | 5 | 2019 | 22350 | 0.130 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9547 | 0.130 |
Why?
|
Tretinoin | 1 | 2019 | 524 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1884 | 0.130 |
Why?
|
Proteomics | 2 | 2024 | 3914 | 0.130 |
Why?
|
Benzimidazoles | 1 | 2021 | 862 | 0.130 |
Why?
|
Fertility | 1 | 2020 | 770 | 0.130 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 326 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2017 | 140 | 0.120 |
Why?
|
Cholesterol | 1 | 2024 | 2903 | 0.120 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 182 | 0.120 |
Why?
|
Pyrazines | 1 | 2021 | 1204 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2019 | 12791 | 0.120 |
Why?
|
Animal Husbandry | 1 | 2015 | 64 | 0.120 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 457 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2004 | 2060 | 0.120 |
Why?
|
Transcription Factors | 5 | 2021 | 12150 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1089 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 637 | 0.120 |
Why?
|
Mice, SCID | 4 | 2021 | 2628 | 0.120 |
Why?
|
Elafin | 1 | 2014 | 29 | 0.120 |
Why?
|
Phthalazines | 1 | 2017 | 397 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2018 | 2839 | 0.110 |
Why?
|
Multiprotein Complexes | 3 | 2016 | 1110 | 0.110 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.110 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3408 | 0.110 |
Why?
|
Epigenomics | 1 | 2019 | 959 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 996 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 434 | 0.110 |
Why?
|
RNA | 2 | 2021 | 2715 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5690 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 265 | 0.110 |
Why?
|
Mice, Knockout | 8 | 2021 | 14471 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2015 | 369 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1621 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5444 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 415 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1762 | 0.100 |
Why?
|
Drug Repositioning | 1 | 2015 | 246 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 950 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2021 | 1757 | 0.100 |
Why?
|
NF-kappa B | 1 | 2021 | 2493 | 0.100 |
Why?
|
Therapies, Investigational | 1 | 2013 | 110 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 428 | 0.100 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 190 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 83 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1576 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3587 | 0.100 |
Why?
|
Private Sector | 1 | 2015 | 396 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2015 | 323 | 0.090 |
Why?
|
Humans | 50 | 2024 | 766766 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9611 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2021 | 3691 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1491 | 0.090 |
Why?
|
Neutrophils | 2 | 2020 | 3782 | 0.090 |
Why?
|
Histones | 1 | 2021 | 2593 | 0.090 |
Why?
|
Naphthyridines | 1 | 2012 | 184 | 0.090 |
Why?
|
Ribosomes | 1 | 2013 | 496 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 496 | 0.080 |
Why?
|
Myeloid Cells | 2 | 2018 | 838 | 0.080 |
Why?
|
Lysosomes | 3 | 2021 | 937 | 0.080 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3250 | 0.080 |
Why?
|
Breast Neoplasms | 4 | 2023 | 21162 | 0.080 |
Why?
|
Oncogene Proteins | 2 | 2016 | 715 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2977 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1966 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2019 | 4276 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2015 | 998 | 0.080 |
Why?
|
Drug Synergism | 2 | 2024 | 1756 | 0.080 |
Why?
|
Oncogenes | 2 | 2021 | 1231 | 0.080 |
Why?
|
Purines | 1 | 2012 | 615 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1802 | 0.070 |
Why?
|
Immunotherapy | 2 | 2021 | 4747 | 0.070 |
Why?
|
Drug Approval | 1 | 2015 | 820 | 0.070 |
Why?
|
Medical Informatics | 1 | 2015 | 744 | 0.070 |
Why?
|
Regeneration | 1 | 2016 | 1520 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11920 | 0.070 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3944 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7208 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1065 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2547 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1168 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1243 | 0.070 |
Why?
|
Mass Spectrometry | 3 | 2022 | 2198 | 0.060 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 658 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4570 | 0.060 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2005 | 71 | 0.060 |
Why?
|
Androgens | 1 | 2013 | 1280 | 0.060 |
Why?
|
Open Reading Frames | 2 | 2020 | 818 | 0.060 |
Why?
|
Models, Biological | 6 | 2018 | 9461 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9525 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4443 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2931 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 463 | 0.060 |
Why?
|
Mice, Nude | 2 | 2021 | 3616 | 0.060 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 195 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4344 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 281 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1982 | 0.060 |
Why?
|
Sterol Regulatory Element Binding Protein 2 | 1 | 2024 | 58 | 0.060 |
Why?
|
Androgen Antagonists | 1 | 2013 | 1411 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 803 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2057 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 22352 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 705 | 0.060 |
Why?
|
Ubiquitination | 2 | 2019 | 1007 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 3043 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 747 | 0.050 |
Why?
|
Proteome | 1 | 2013 | 1894 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1838 | 0.050 |
Why?
|
Male | 21 | 2021 | 364142 | 0.050 |
Why?
|
Keratin-7 | 1 | 2023 | 55 | 0.050 |
Why?
|
Mitosis | 2 | 2024 | 1176 | 0.050 |
Why?
|
Proteins | 3 | 2018 | 6002 | 0.050 |
Why?
|
Endosomes | 2 | 2016 | 521 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2004 | 740 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1677 | 0.050 |
Why?
|
Acetyl Coenzyme A | 1 | 2022 | 74 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6104 | 0.050 |
Why?
|
Protein Stability | 1 | 2024 | 578 | 0.050 |
Why?
|
Phosphorylation | 2 | 2024 | 8307 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Telomerase | 1 | 2006 | 750 | 0.050 |
Why?
|
Gene Amplification | 2 | 2018 | 1088 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 1996 | 0.050 |
Why?
|
Blotting, Western | 2 | 2009 | 5022 | 0.050 |
Why?
|
Gene Silencing | 3 | 2018 | 1504 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3531 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3425 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1751 | 0.050 |
Why?
|
Cell Cycle | 2 | 2024 | 2926 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7585 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 630 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 361 | 0.040 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1150 | 0.040 |
Why?
|
RNA, Small Nucleolar | 1 | 2019 | 27 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1150 | 0.040 |
Why?
|
HeLa Cells | 1 | 2005 | 3073 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 259 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1521 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 260 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 928 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3757 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 321 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11872 | 0.040 |
Why?
|
COS Cells | 1 | 2020 | 1135 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 896 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2018 | 365 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5700 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 2827 | 0.030 |
Why?
|
Endocytosis | 1 | 2021 | 951 | 0.030 |
Why?
|
Deoxycytidine | 1 | 2021 | 886 | 0.030 |
Why?
|
Cell Communication | 1 | 2024 | 1660 | 0.030 |
Why?
|
Methylation | 1 | 2019 | 1074 | 0.030 |
Why?
|
K562 Cells | 1 | 2018 | 645 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1716 | 0.030 |
Why?
|
RNA Splicing | 1 | 2021 | 903 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1129 | 0.030 |
Why?
|
Cytarabine | 1 | 2018 | 696 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 2001 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 251 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1926 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 245 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4924 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 938 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1900 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3702 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2017 | 476 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4349 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 735 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1062 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 960 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1103 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1020 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1227 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2018 | 682 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1895 | 0.030 |
Why?
|
Heterozygote | 2 | 2011 | 2795 | 0.030 |
Why?
|
Protein Binding | 1 | 2005 | 9320 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2392 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 381 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 800 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 4018 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1675 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 557 | 0.030 |
Why?
|
Valine | 1 | 2014 | 410 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2016 | 840 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3609 | 0.030 |
Why?
|
Gene Duplication | 1 | 2013 | 315 | 0.030 |
Why?
|
Nanostructures | 1 | 2017 | 549 | 0.020 |
Why?
|
Cell Membrane | 1 | 2021 | 3641 | 0.020 |
Why?
|
Testosterone | 1 | 2023 | 2495 | 0.020 |
Why?
|
Organ Specificity | 1 | 2016 | 1966 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1105 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13036 | 0.020 |
Why?
|
Phenylthiohydantoin | 1 | 2013 | 206 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5754 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 663 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3581 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 465 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2902 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1711 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1155 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6512 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 15563 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 391 | 0.020 |
Why?
|
Fatty Acids | 1 | 2018 | 1806 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6895 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1018 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2534 | 0.020 |
Why?
|
Female | 8 | 2024 | 396520 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2010 | 122 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1604 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2011 | 327 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4142 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 439 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5199 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10100 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4522 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1181 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1663 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2903 | 0.020 |
Why?
|
Mammals | 1 | 2013 | 1133 | 0.020 |
Why?
|
Nitriles | 1 | 2013 | 981 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 18984 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 861 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4340 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1375 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 81 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 65273 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2659 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2012 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1057 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1211 | 0.020 |
Why?
|
Homozygote | 1 | 2010 | 1775 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 3077 | 0.010 |
Why?
|
Zebrafish | 1 | 2016 | 3035 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4784 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1675 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1718 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6359 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2669 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1351 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5783 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2010 | 2093 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12415 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7609 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13411 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2391 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 17608 | 0.010 |
Why?
|
Lung | 1 | 2019 | 10067 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10264 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3450 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2467 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29948 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 945 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4166 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5890 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5789 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1404 | 0.010 |
Why?
|
Middle Aged | 2 | 2023 | 223257 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9404 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11651 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59550 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2534 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11061 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 18075 | 0.000 |
Why?
|
Aged | 1 | 2020 | 171343 | 0.000 |
Why?
|
Adult | 1 | 2020 | 223307 | 0.000 |
Why?
|